Cristian Moreno – Managing Director – Torque Metals (ASX:TOR) is an exploration company with a proven discovery methodology, combining drilling results with machine learning algorithms and geological interpretation.
Copyright 2024 – Finance News Network
09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.
15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
22 Jun 2023 - Magnis Energy Technologies Limited (ASX:MNS) Managing Director (US) Hoshi Daruwalla discusses the UN/DOT 38.3 certification awarded to lithium-ion batteries produced at the IM3NY battery plant.
2 Aug 2022 - Laybuy Holdings Limited (ASX:LBY) Co-Founder and Managing Director Gary Rohloff discusses quarterly results, restructuring of the company and outlook.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
09 Mar 2020 - Lithium Power International Limited (ASX:LPI) Managing Director and CEO Cristobal Garcia-Huidobro and Executive Director and CFO Andrew Phillips discuss the Environmental Approval for the company's Maricunga lithium brine project in Northern Chile, what this means for the project, and what’s planned.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
01 Apr 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari introduces the company, discussing the use of radiopharmaceuticals for cancer treatment and the company's upcoming trial in non-small cell lung cancer.
